Furthermore, studies have reported that overexpression of the c-MET ligand HGF can also mediate resistance of NSCLC cells to ALK TKIs through the activation of the MET bypass signaling pathway (82, 83). This evidence concerns the gene ALK and non-small cell lung carcinoma.